Achieve Life Sciences (ACHV) Current Assets (2010 - 2026)

Achieve Life Sciences has disclosed Current Assets across 17 years of filings, most recently posting $31.1 million for Q1 2026.

• Quarterly Current Assets rose 24.24% year-over-year to $31.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $31.1 million (up 24.24% YoY) and the FY2025 annual result came in at $39.9 million, up 9.38% from the prior year.
• Current Assets retreated to $31.1 million in Q1 2026, from $39.9 million in the prior quarter.
• Over five years, Current Assets peaked at $67.7 million in Q1 2024 and troughed at $17.0 million in Q4 2023.
• A 5-year average of $36.2 million and a median of $31.1 million in 2022 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2024 — Current Assets surged 271.54% — and 2025, when it plunged 63.08%.
• Tracing ACHV's Current Assets over 5 years: stood at $27.3 million in 2022, then tumbled by 37.86% to $17.0 million in 2023, then jumped by 114.74% to $36.5 million in 2024, then climbed by 9.38% to $39.9 million in 2025, then slipped by 22.13% to $31.1 million in 2026.
• Business Quant data shows ACHV's Current Assets at $31.1 million in Q1 2026, $39.9 million in Q4 2025, and $50.1 million in Q3 2025.